PMID- 25804415 OWN - NLM STAT- MEDLINE DCOM- 20160517 LR - 20220408 IS - 1549-9642 (Electronic) IS - 1549-9634 (Linking) VI - 11 IP - 6 DP - 2015 Aug TI - Advances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regeneration. PG - 1551-73 LID - S1549-9634(15)00075-1 [pii] LID - 10.1016/j.nano.2015.03.002 [doi] AB - Current advances in novel drug delivery systems (DDSs) to release growth factors (GFs) represent a great opportunity to develop new therapies or enhance the effectiveness of available medical treatments. These advances are particularly relevant to the field of regenerative medicine, challenging healthcare issues such as wound healing and skin repair. To this end, biocompatible biomaterials have been extensively studied to improve in vivo integration of DDSs, to enhance the bioactivity of the released drugs and to deliver bioactive molecules in a localised and controlled manner. Thus, this review presents an overview of DDSs to release GFs for skin regeneration, particularly emphasising on (i) polymeric micro and nanospheres, (ii) lipid nanoparticles, (iii) nanofibrous structures, (iv) hydrogels and (v) scaffolds. In addition, this review summarises the current animal models available for studying wound healing and the clinical trials and marketed medications based on GF administration indicated for chronic wound treatment. FROM THE CLINICAL EDITOR: Chronic wounds currently pose a significant burden worldwide. With advances in science, novel drug delivery systems have been developed for growth factors delivery. In this comprehensive review, the authors highlighted current drug delivery systems for the enhancement of wound healing and their use in clinical settings. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Gainza, Garazi AU - Gainza G AD - NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country, Vitoria, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria, Spain. FAU - Villullas, Silvia AU - Villullas S AD - Biopraxis Research AIE, Minano 01510, Spain. FAU - Pedraz, Jose Luis AU - Pedraz JL AD - NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country, Vitoria, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria, Spain. FAU - Hernandez, Rosa Maria AU - Hernandez RM AD - NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country, Vitoria, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria, Spain. FAU - Igartua, Manoli AU - Igartua M AD - NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country, Vitoria, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria, Spain. Electronic address: manoli.igartua@ehu.es. LA - eng PT - Journal Article PT - Review DEP - 20150321 PL - United States TA - Nanomedicine JT - Nanomedicine : nanotechnology, biology, and medicine JID - 101233142 RN - 0 (Growth Substances) SB - IM MH - Animals MH - *Drug Delivery Systems MH - Growth Substances/*administration & dosage MH - Humans MH - *Regeneration MH - Skin/*physiopathology MH - *Wound Healing OTO - NOTNLM OT - Drug delivery system OT - Growth factor OT - Microparticle OT - Nanosphere OT - Skin regeneration OT - Wound healing EDAT- 2015/03/26 06:00 MHDA- 2016/05/18 06:00 CRDT- 2015/03/26 06:00 PHST- 2014/10/10 00:00 [received] PHST- 2015/03/03 00:00 [revised] PHST- 2015/03/03 00:00 [accepted] PHST- 2015/03/26 06:00 [entrez] PHST- 2015/03/26 06:00 [pubmed] PHST- 2016/05/18 06:00 [medline] AID - S1549-9634(15)00075-1 [pii] AID - 10.1016/j.nano.2015.03.002 [doi] PST - ppublish SO - Nanomedicine. 2015 Aug;11(6):1551-73. doi: 10.1016/j.nano.2015.03.002. Epub 2015 Mar 21.